Cyclerion Therapeutics (CYCN) Stock Chart & Stock Price History $3.86 -1.46 (-27.44%) (As of 02:57 PM ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Cyclerion Therapeutics Stock Price Performance 5 Day Performance+141.82%1 Month Performance+104.62%3 Month Performance+74.43%6 Month Performance+100.00%Year-To-Date Performance+58.81%1 Year Performance+124.73% Receive CYCN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Could you have done better than this? (Ad)Let me show you how well my “2-Click Trade” could have worked out for you in November last year. You might remember that the stock market was red hot. The S&P 500, Bonds, Gold, Bitcoin… everything was heading higher. And the rally was fueled by top stocks like Apple and Microsoft, both of which gained around 10% for the month. Any amount you’d invested in those two stocks would have given you an 11% return. Had you used my “2-Click Trade” on just one, specific ticker… You could have done so much better…If you prefer a strategy that targets better returns, click here to get more details on the “2-Click CYCN Stock Chart for Friday, December, 6, 2024 CYCN Chart by TradingView Cyclerion Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/05/2024$6.35$5.32-16.22%$5.70$4.553.41 million shs$14.42 million12/04/2024$1.61$6.35+294.41%$9.47$4.61141.66 million shs$17.21 million12/03/2024$2.34$1.61-31.20%$2.26$1.57375,084 shs$6.34 million12/02/2024$2.20$2.34+6.36%$2.38$2.10385,034 shs$6.34 million11/29/2024$2.16$2.20+1.85%$2.33$2.03985,112 shs$5.96 million11/28/2024$2.16$2.16$2.34$1.7229.94 million shs$5.85 million Get the Latest News and Ratings for CYCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/27/2024$1.36$2.16+58.82%$2.34$1.7229.88 million shs$5.85 million11/26/2024$1.45$1.36-6.21%$1.47$1.33132,151 shs$3.69 million11/25/2024$1.43$1.45+1.40%$1.59$1.45108,176 shs$3.93 million11/22/2024$1.82$1.43-21.43%$1.55$1.2779,641 shs$3.88 million11/21/2024$2.09$1.82-12.92%$1.99$1.55475,071 shs$4.93 million11/20/2024$1.76$2.09+18.75%$2.27$1.78136,479 shs$5.66 million11/19/2024$2.09$1.76-15.79%$2.22$1.73113,501 shs$4.77 million11/18/2024$2.58$2.09-18.99%$2.53$2.00449,450 shs$5.66 million11/15/2024$1.77$2.58+45.76%$2.99$1.7611.98 million shs$6.99 million11/14/2024$1.83$1.77-3.28%$1.83$1.7128,114 shs$4.80 million11/13/2024$1.81$1.83+1.10%$2.01$1.7751,247 shs$4.96 million11/12/2024$2.56$1.81-29.30%$2.63$1.7171,630 shs$4.91 million11/11/2024$2.53$2.56+1.19%$2.76$2.4710,370 shs$6.94 million11/08/2024$2.48$2.67+7.66%$2.72$2.5011,726 shs$7.24 million11/07/2024$2.60$2.48-4.62%$2.80$2.4614,259 shs$6.72 million11/06/2024$2.70$2.60-3.70%$2.79$2.6021,034 shs$7.05 million11/05/2024$2.64$2.70+2.27%$2.99$2.6437,953 shs$7.32 million Related Companies LPCN Stock Chart GOVX Stock Chart LSTA Stock Chart ENLV Stock Chart SPRB Stock Chart FLGC Stock Chart PULM Stock Chart CTXR Stock Chart BLRX Stock Chart MIRA Stock Chart Receive CYCN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYCN) was last updated on 12/6/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElon declares war on company he co-founded!?Elon Musk is leading humanity into the new era of AI. He’s just received a fresh $6 billion in funding for ...Porter & Company | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | SponsoredThis Company is Helping Brands Go Digital with Innovative Solutions.The growth of social media, e-Commerce, AI adoption and digital transformation has created an enormous window ...Huge Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclerion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclerion Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.